Joint Economic Committee examines healthcare fraud controls and spending incentives

Joint Economic Committee examines healthcare fraud controls and spending incentives
Curbing healthcare fraud now

U.S. lawmakers and health policy experts are pressing for structural changes to curb healthcare fraud and reduce waste across federal programs. The debate centers not only on explicit fraud, but also on payment incentives and oversight gaps that can drive higher spending in Medicare and Medicaid.

Highlights

  • Joint Economic Committee hearing on June 24 spotlighted structural flaws and misaligned incentives in Medicare Advantage driving ongoing waste and fraud.
  • Experts testified that while AI and analytics improve payment irregularity detection, core incentive structures remain unchanged, requiring deeper reforms and enhanced oversight.
  • Witnesses identified fragmented Medicaid oversight, inadequate data sharing, and weak congressional controls as drivers of persistent inefficiency and rising healthcare program costs.

Hearing focuses on fraud detection and incentive reform

As reported by the Joint Economic Committee, a June 24 hearing examined how fraud, weak oversight and misaligned payment structures affect healthcare spending, with testimony from experts in health policy, law and program administration.

Chairman Rep. David Schweikert says policymakers are too often focused on narrow fixes instead of broader reforms that could better align incentives in programs such as Medicare Advantage. He argues that structural changes are needed to stop what he describes as leakage of taxpayer funds and to move beyond recurring debates over waste, fraud and abuse.

Witnesses say technology can help identify suspicious payments earlier, but they stress that data tools alone do not solve the underlying problem. Dr. Brian Blase says artificial intelligence and analytics may improve detection, while Dr. David Meyers adds that the same technologies can also be used within the system to increase payments, leaving core incentives unchanged.

Discussion also turns to whether longer enrollment periods in Medicare Advantage or broader use of capitation could encourage better long-term care management. Witnesses say those approaches may improve incentives, but they still require strong oversight and safeguards against abuse.

Oversight gaps raise concerns for Medicaid and federal spending

Experts at the hearing describe Medicaid as highly fragmented, with different structures and rules across states that make spending harder to track. Dr. Chris Pope says limited visibility into how funds are used can prevent policymakers from spotting inefficiencies and avoiding unintended consequences.

Jessica Tillipman says disconnected systems create vulnerabilities that can make fraud harder to detect and prevent. She points to stronger data sharing and whistleblower protections as important tools, and says existing recommendations from oversight bodies could help if they are carried out.

Blase says the persistence of waste and abuse is tied in part to financing arrangements that encourage states to maximize federal matching funds rather than restrain costs. The hearing also highlights the limits of the current pay-and-chase model, with lawmakers and witnesses backing a greater use of data-driven systems that can flag or block suspect transactions before money is paid out.

The broader discussion links healthcare fraud prevention to rising program costs, weak congressional oversight and industry consolidation. Participants argue that without changes to the way incentives are set, U.S. healthcare programs will continue to face systemic inefficiencies that raise costs for patients and taxpayers.

Our earlier coverage of the House oversight hearing on alleged waste, fraud and abuse in SNAP explained lawmakers’ concerns that improper payments and trafficking losses are hard to fully measure without broader access to state beneficiary and transaction data. The article highlighted findings on eligibility-verification failures and examples of potential fraud uncovered from the states that did comply, alongside calls for stronger safeguards and data sharing to tighten program oversight.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.